VOLITIONRX LIMITED

1 Scotts Road

#24-05 Shaw Centre

Singapore 228208

 

 

October 11, 2018

 

 

SUBMITTED VIA EDGAR

 

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:  Dorrie Yale

 

Re:VolitionRx Limited Acceleration Request 

Registration Statement on Form S-3

File No. 333-227731

 

Requested Date:October 15, 2018 

Requested Time:5:00 P.M. Eastern Time 

 

Dear Ms. Yale:

 

Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.

 

Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth, P.C., via telephone at (949) 725-4136 or via email at malcser@sycr.com.

 

Sincerely,

 

VOLITIONRX LIMITED

 

/s/ Cameron Reynolds

 

Cameron Reynolds

President and Chief Executive Officer

 

cc:

 

Stradling Yocca Carlson & Rauth, P.C.

Marc G. Alcser, Esq.